Skip to main content

Revolutionizing Early-Stage NSCLC Treatment: Pathologists' Key Insights into Predicting Pathologic Responses to Immunotherapies

Description: This live, virtual webcast is designed to update clinicians involved in the management of NSCLC on the use of immunotherapy for early-stage disease. In particular, the role of molecular testing as it relates to predicting potential benefit from immunotherapy will be a main topic of focus, with emphasis from the faculty panel on potential biomarkers that may help identify optimal therapies along the treatment journey.

Program Chair: Melissa Johnson, MD

Edward Garon, MD, MS, Prof. Solange Peters, MD, PhD, Ignacio I. Wistuba, MD